and Eschwège E. Is insulin an independent risk factor for hypertension? The Paris Prospective Study. International Journal of Epidemiology 1997; 26: 542-550. Background. The link between hyperinsulinaemia and hypertension has been examined in few prospective studies and often diminished after adjustment for obesity, central adiposity and baseline blood pressures. Methods. The incidence of hypertension was studied as a function of baseline insulin and glucose in 4149 Caucasian, non-hypertensive, non-diabetic middle-aged men from the Paris Prospective Study. Blood pressures were measured over the 3 years of follow-up; hypertension incidence was defined as systolic blood pressure у160 mmHg or diastolic blood pressure у95 mmHg or drug treatment for hypertension. Results. Fasting and 2-hour glucose and insulin were predictive of hypertension, after controlling for the known risk factors: age, excessive alcohol consumption and family history of hypertension (FHH). However, after further controlling for body mass index and central adiposity (the iliac circumference), insulin was no longer predictive in men without an FHH. When weight variation was also taken into account, and further adjustment made for baseline blood pressure and heart rate, fasting insulin, only, was predictive when the subject had a weight increase, independently of FHH. Fasting glucose was predictive of hypertension except in the case of no change or weight decrease and a negative FHH; 2-hour glucose was predictive in the presence of a positive FHH. Conclusions. Insulin and glucose levels were both risk factors for hypertension, and this risk was enhanced in the case of a positive FHH. However, obesity, especially central obesity, confounded these relationships and might be an intermediary factor in the relationship between insulin and hypertension.
While insulin has been shown to be a risk factor of cardiovascular disease in five prospective epidemiological studies, [1] [2] [3] [4] [5] other studies have not confirmed these results. 6 In contrast, hypertension is an accepted risk factor for cardiovascular disease, but treatment for hypertension with diuretics or beta-blockers does not decrease the risk of coronary heart disease as much as might be expected from epidemiological studies. 7 A hypothesis which might explain this apparent discrepancy is that another abnormality, associated with hypertension and not corrected by anti-hypertensive treatment, may be involved in cardiovascular diseases.
Reaven 8 described the insulin resistance syndrome as the association of a number of abnormalities: insulin resistance, hyperinsulinaemia, glucose intolerance, increase of very low density triglycerides, decrease of high density lipoprotein cholesterol and hypertension. Björntorp 9, 10 and more recently Reaven 11 added obesity, emphasizing an abdominal fat distribution. Insulin resistance is thought to be the underlying abnormality of this syndrome 12 and the fasting insulin concentration is its surrogate in non-diabetic subjects. 13, 14 Many crosssectional studies have found associations between the different abnormalities of the insulin resistance syndrome, in particular between hypertension and insulin, [15] [16] [17] [18] [19] [20] [21] [22] [23] but results differ according to ethnicity and sex: the relation seems to hold in Caucasians and in men. In many studies, the link between these two disorders diminishes after adjustment for obesity and abdominal fat. Few prospective studies have examined the link between insulin and hypertension incidence [24] [25] [26] [27] [28] [29] [30] [31] and results have not been consistent.
We examined the relationship between insulin and glucose levels and the risk of developing hypertension in 4149 active, middle-aged Caucasian men from the Paris Prospective Study, taking into consideration the possible confounding effects of obesity and abdominal fat distribution.
MATERIALS AND METHODS

Research Design
The Paris Prospective Study included, between 1967 and 1972, 7991 Paris policemen. They were aged 43-54 years at the time of the first screening which consisted of a questionnaire about health and habits and anthropometric measurements including height (to the nearest cm) with the subject wearing no shoes, and iliac circumference (at the iliac crest level, to the nearest mm). In the second year, the baseline year for this analysis, a blood sample was taken at fasting and following a 75 g oral glucose tolerance test to measure plasma glucose (G 0 , G 2 ), and insulin (I 0 , I 2 ) by a radioimmunological assay. 32 In the second year and during the subsequent three years of follow-up, weight was measured to the nearest 0.5 kg with the subject wearing light clothing and blood pressures were taken once at each exam by the same trained team. Subjects were seated for 15 min and the first and fourth Korotkoff sounds were measured on the right arm to the nearest 10 mmHg (a diastolic blood pressure (DBP) of 95 was recorded as 100 mmHg but a DBP of 94 was recorded as 90 mmHg). The heart rate was also recorded at the same time.
Hypertension was defined according to the WHO criteria 33 but at only one examination: DBP у95 mmHg (recorded as у100 mmHg in our study) and/or systolic blood pressure (SBP) у160 mmHg and/or current use of antihypertensive medications. A subject who had readings which were elevated at the first follow-up visit but not at the next one was declared hypertensive at the first visit. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m 2 ). A family history of hypertension (FHH) included hypertension in any parent, brother or sister. Excessive alcohol consumption was defined by a clinical examination typical of either cirrhosis or clinical alcoholism or by a mean corpuscular volume Ͼ98 µ 3 , a marker linearly related with alcohol intake. 34 For this analysis, we selected the 4149 men born in France, attending the second examination, not diabetic or hypertensive at baseline, with no missing values for baseline blood pressures, fasting and 2-hour insulin and glucose, BMI, iliac circumference, excessive alcohol consumption and FHH.
Statistical Analysis
Analysis of covariance and χ 2 tests were used for comparing means and prevalences between subgroups. Insulin levels were log-transformed. The significance of the difference in hypertension rates between groups was determined by a χ 2 test for stratified incidence data. 35 The relationship between baseline variables and hypertension incidence was assessed by Cox's proportional hazards regression analysis. 36 Systolic blood pressure was used as a categorical variable because precise measures were not available. For each continuous variable, the hazard ratio of developing hypertension was calculated comparing the 90th and 10th percentiles. Adjustment was made for factors known to be predictive of hypertension: age, BMI, central adiposity (iliac circumference), body weight variation, FHH, excessive alcohol consumption, baseline SBP and heart rate, a marker of stress. 37 The interaction between variables was evaluated by a likelihood ratio test. 38 The validity of the proportional hazards assumption for the covariates was verified as suggested by Kalbfleish and Prentice. 39 For most of the analyses, age and baseline SBP violated the proportionality assumption. Proportional hazards models, therefore, were stratified by SBP at baseline (100-120 mmHg; 130 mmHg; 140 mmHg; 150 mmHg) and two age groups divided by the median (49.3 years) in order to control for these variables.
All statistical analyses used the SAS statistical package. A statistically significant level was defined as P Ͻ 0.05.
RESULTS
The length of follow-up among the 4149 nonhypertensive men at baseline was 3.16 ± 1.35 years (mean ± SD). Table 1 shows the characteristics of the subjects at baseline. Prevalences of excessive alcohol consumption and FHH were 29% and 44% respectively. When adjusted for age, the 738 (18%) men lost to follow-up before the occurrence of hypertension and the last examination had a higher prevalence of excessive alcohol consumption (P Ͻ 0.001), lower mean insulin (P = 0.01 for fasting and 2-hour insulin) and higher heart rate (P = 0.02) than subjects who were followed up. Mean blood pressures were similar. The 47 subjects (1%) who died during the 3 years of followup before the occurrence of hypertension had a higher prevalence of excessive alcohol consumption (P Ͻ 0.001) and higher 2-hour insulin (P = 0.004), 2-hour glucose (P = 0.002) and heart rate (P = 0.006) but similar blood pressures to other subjects. There were 116 men with missing information for weight during the 3 years of follow-up, but there were no significant differences between the groups with and without missing values for body weight variation (data not shown). The incidence rate of hypertension was 78.9 per 1000 person-years. Incidence rates of hypertension according to fasting insulin divided by the quartiles are shown in Figure 1 by strata of FHH and weight variation divided by the median. Men in the higher two quartiles for fasting insulin had higher incidence rates of hypertension if the FHH was positive, and among those with similar FHH, men with a weight increase had higher rates (for the first and the second highest insulin quartiles, respectively, P for trend Ͻ0.001 and P = 0.04). This difference was not observed in men in the lower two insulin quartiles (P for trend = 0.60). To emphasize the influence of obesity, especially central adiposity, on the relationship between fasting insulin and hypertension, the incidence rates of hypertension are shown according to fasting insulin, and by strata of BMI and iliac circumference divided by the median (Figure 2 ). At all insulin levels, men with high iliac circumference had highest incidence rates of hypertension, and among those with similar iliac circumference, men with high BMI had higher incidence rates (P for trend Ͻ0.001 at all insulin levels), but this effect was stronger in men with high fasting insulin level.
In proportional hazards models, a positive FHH but not an excessive alcohol consumption was a predictive factor for hypertension (Table 2) . However, further adjustments took into account an excessive alcohol consumption because of its known predictive value for hypertension in other populations. Body mass index, iliac circumference, blood pressures, heart rate, and weight variation were predictive of hypertension when controlled for age, excessive alcohol consumption and FHH. Because of a positive and significant interaction between a FHH and insulin levels (P = 0.03 with fasting insulin and P = 0.05 with 2-hour insulin), analyses were performed separately in men with a positive and with a negative FHH. Men with a positive FHH had higher age-adjusted means for SBP (P = 0.002) and BMI (P = 0.02) as compared to men with a negative FHH, but mean glucose and insulin concentrations were similar. Fasting and (Table 3) . When controlled for age, excessive alcohol consumption, BMI and iliac circumference, insulin levels were predictive of hypertension only in subjects with a positive FHH. Fasting and 2-hour glucose were significant predictive factors whatever the FHH.
A significant and positive interaction term was found between weight variation and both fasting and 2-hour insulin (P Ͻ 0.001) in subjects with no missing values for weight variation (n = 4033). Therefore, analyses were divided by the median of weight variation into men with weight increase, and men with no change or weight decrease. Men with weight increase had at baseline lower age-adjusted fasting insulin, fasting and 2-hour glucose, BMI, heart rate and blood pressures (P Ͻ 0.001 for all variables) but not significantly lower 2-hour insulin (P = 0.09) than men with no change or weight decrease. When controlled for age, excessive alcohol consumption, BMI, iliac circumference, SBP and heart rate, fasting insulin was a significant risk factor for hypertension whatever the FHH, but only in men with a weight increase: fasting insulin was a significant protective factor in the case of a negative FHH and no change or weight decrease (Table 4) . Two-hour insulin was not a risk factor for hypertension. Fasting glucose was a risk factor for hypertension when there was a positive FHH, and, if the FHH was negative, in the case of a weight increase. Two-hour glucose was a significant risk factor in the case of a positive FHH whatever the weight variation. No difference was observed for insulin and glucose as risk factors for hypertension between subgroups of men who decreased their weight or remained weight-stable (data not shown). The hazards ratios for insulin and glucose differed between the four FHH and weight variation groups (P Ͻ 0.02) except for 2-hour glucose (P = 0.21). In forward stepwise models (P = 0.05 for entry into the model) controlled for age, excessive alcohol consumption, BMI, iliac circumference, SBP and heart rate, the fasting and 2-hour insulin and glucose concentrations that entered into the four different models were: fasting insulin for men with a negative FHH and no change or weight decrease (protective factor, P = 0.01); fasting glucose for men with a negative FHH but weight increase (risk factor, P = 0.04); fasting glucose for men with a positive FHH but no change or weight decrease (risk factor, P = 0.03); and fasting glucose and then fasting insulin for men with a positive FHH and weight increase (risk factors, P = 0.01 and P = 0.02, respectively).
DISCUSSION
Essential hypertension is partly a genetic disease and we found that a positive FHH, which may partially account for a genetic risk factor, was a predictive factor for hypertension. In other studies, higher levels of insulin have been found in offspring of subjects with hypertension, as compared to control subjects.
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While we did not find such differences at baseline, offspring of subjects with hypertension had higher baseline blood pressures and BMI. We found that insulin was a risk factor for hypertension only in the case of a positive FHH after controlling for obesity, and that the predictive value of glucose was greater in this case. Therefore, our results support the hypothesis of a strong genetic component for the relationship between insulin and hypertension, whereas this component was less strong for the relationship between glucose and hypertension. Seven prospective studies have analysed the relationship between insulin and hypertension incidence. When controlled for obesity, insulin was predictive of hypertension in Finnish subjects, 24 in Swedish men 25 and women, 26 in white subjects of the Cardia study 30 and only in the lean subjects of the San Antonio 27 and the San Luis Valley 29 studies. However, this relationship was not controlled for baseline blood pressures in three studies, 24, 26, 27 it was no longer significant when controlled for in three other studies, 25, 29, 31 and remained significant in only one study. 30 The peculiarity of the Paris Prospective Study population in comparison to others is that the participants were middle-aged policemen who had a high alcohol consumption 45 and probably high levels of stress. We controlled for these two factors but a lack of accuracy in the two surrogate measures used (our definition of an excessive alcohol consumption was not a significant predictor for hypertension) may still be responsible for some confounding effect. However, insulin was found to be a risk factor for cardiovascular disease in this population, 3 which may imply a closer link between insulin and hypertension. Weight gain, BMI and iliac circumference, a measure of central adiposity linked with cardiovascular diseases in this population, 46 were all strong predictive factors for hypertension in our study. However, the predictive relationship between insulin and hypertension was dependent on BMI and iliac circumference in subjects with a negative FHH, and insulin was a risk factor only in the case of weight gain when controlled for obesity, blood pressure and heart rate, which were strong predictive factors of hypertension. Nevertheless, residual confounding due to BMI, central adiposity, alcohol consumption, etc., could remain and be partially responsible for the former relationship. The results of the present study suggest that obesity may be an intermediary factor in the relationship between insulin and hypertension and that environmental factors are an important component of this relationship.
There are a number of possible explanations for the low predictive power of insulin for hypertension incidence in men with a negative FHH or no change or weight decrease. First, the 3-year incidence of hypertension was high (78.9 per 1000 person-years) as compared to other studies. [25] [26] [27] [28] 47 Although the men studied were at high risk for hypertension because of their age and social characteristics, misclassification, because the definition of hypertension was based on a single measurement and on the first and fourth Korotkoff sound, may have resulted in some overestimation of incidence, even though a single measurement of blood pressure may be accurate in epidemiological studies. 48 This may have decreased the likelihood of detecting risk factors. The lack of accuracy in the measurement of blood pressure (to the nearest 10 mmHg) is another limitation of the present study: the methodology we used (Cox models and stratification by class of blood pressure at baseline to respect the proportionality assumption) partially avoided this inaccuracy by using classes for blood pressure. A DBP of 95 mmHg was recorded as 100 mmHg and the subject as hypertensive, whereas a DBP of 94 mmHg was recorded as 90 mmHg and the subject as normotensive in any case. Nevertheless, an SBP record of 156 mmHg would have been recorded as 160 mmHg, and the subject included as hypertensive. Another explanation for the low predictive power of insulin for hypertension incidence is that a prevalenceincidence bias may have occurred in these middle-aged subjects: 49 hypertensive subjects were excluded, but they were the most hyperinsulinaemic and would have the greatest exposure if insulin is a real risk factor for hypertension. Moreover, confounding pro-insulin and insulin would also decrease the predictive power of insulin on hypertension, as the assays used in this study measured both insulin and pro-insulin. As shown in the San Antonio Study, pro-insulin rather than insulin itself may be the real risk factor for cardiovascular diseases 50, 51 but both SBP and DBP were correlated with fasting and 2-hour pro-insulin and true insulin. 52 Finally, we found that subjects who gained weight had lower baseline fasting insulin, as has been shown in the Pima Indians 53 and it has been suggested that hyperinsulinaemia may represent physiological adaptations to obesity that limit further fat deposition. Therefore, hyperinsulinaemia may also be responsible for a limiting of hypertension incidence in our study.
According to physiopathological hypotheses about the effects of insulin on blood pressure levels, insulin is an anti-natriuretic factor, [54] [55] [56] but there has been no evidence of insulin leading to hypertension through this action. 57 Another mechanism found in experimental studies is the stimulation of the sympathic nervous system, 58, 59 but a decrease in the peripheral vascular vessel resistance may counterbalance this effect, resulting in no increase in blood pressure. 57 Obese subjects may have a reduced inhibition of peripheral vascular vessel resistance that cannot counterbalance the stimulation of the sympathetic system which seems intact. [60] [61] [62] [63] This may explain the confounding effect of BMI and iliac circumference on the relationship between insulin and hypertension, and the predictive power of insulin on hypertension that we observed only when there was a weight gain, even after adjustment for heart rate, a surrogate measure of stress.
In our study, glucose was a stronger predictive factor for hypertension than insulin after controlling for obesity. Results from the cross-sectional analysis of the Paris Prospective Study suggested such a link 64 and similar results have also been observed in a Finnish study. 65 Glucose may be involved in hypertension incidence through non-enzymatic glycation of proteins and production of free radicals:
66 a reduction of antioxidant defence is now an established cardiovascular risk factor and is hypothesized to play a role in the development of hypertension. In fact, in our study, the predictive value of glucose was stronger in the case of a positive FHH, which may account for a different effect of hyperglycaemia-related increased free radical production due to a genetic contribution, independently of obesity.
In conclusion, in a population where insulin has been shown to be a risk factor for cardiovascular diseases, after controlling for obesity, a high fasting insulin concentration was predictive of hypertension only in subjects who gained weight over the 3 years of followup. Fasting glucose was a significant predictive factor even after controlling for obesity, except in the case of no change or weight decrease and a negative FHH, and 2-hour glucose was predictive in the presence of a positive FHH. We conclude that both glucose and fasting insulin levels were risk factors for hypertension, particularly in the case of a FHH, which may partially account for a genetic predisposition. However, environmental factors confounded these relationships, and obesity, especially central obesity, might be an intermediary factor in the relationship between insulin and hypertension.
